Decreased glutathione transferase activity in brain and ventricular fluid in Alzheimer's disease

Neurology

Volumn 51, Issue 6, 1998, Pages 1562-1566

  Lovell, M A ^a,b,c   Xie, C ^a,b,c   Markesbery, W R ^a,b,c  

^a Department of Chemistry ^*  (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

^c UNIVERSITY OF KENTUCKY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 HYDROXYNONENAL; GLUTATHIONE TRANSFERASE; POLYUNSATURATED FATTY ACID;

AGED; ALZHEIMER DISEASE; AMYGDALOID NUCLEUS; ARTICLE; AUTOPSY; CEREBROSPINAL FLUID; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; HIPPOCAMPUS; HUMAN; HUMAN TISSUE; LIPID PEROXIDATION; MALE; OLIVARY NUCLEUS; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; SUBICULUM;

EID: 0031678044     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.51.6.1562     Document Type: Article

References (38)

1. Prasad MR, Lovell MA, Yatin M, Dhillon H, Markesbery WR. Regional membrane phospholipid alterations in Alzheimer's disease. Neurochem Res 1998;23:81-88.
2. Lovell MA, Ehmann WD, Butler SM, Markesbery WR. Elevated thiobarbituric acid-reactive substances and antioxidant enzyme activity in the brain in Alzheimer's disease. Neurology 1995;45:1594-1601.
3. Hensley K, Hall N, Subramaniam R, et al. Brain regional correspondence between Alzheimer's disease histopathology and biomarkers of protein oxidation. J Neurochem 1995;65: 2146-2156.
4. Mecocci P, MacGarvey U, Beal MF. Oxidative damage to mitochondrial DNA is increased in Alzheimer's disease. Ann Neurol 1994;36:747-751.
5. Markesbery WR. Oxidative stress hypothesis in Alzheimer's disease. Free Radie Biol Med 1997;23:134-147.
6. Esterbauer H, Schaur RJ, Zollner H. Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radie Biol Med 1991;11:81-128.
7. Bruce-Keller AJ, Li Y-J, Lovell MA, et al. 4-Hydroxynonenal, a product of lipid peroxidation, damages cholinergic neurons and impairs visuospatial memory in rats. J Neuropathol Exp Neurol 1998;57:257-269.
8. Mark RJ, Lovell MA, Markesbery WR, Uchida K, Mattson MP. A role for 4-hydroxynonenal, an aldehydic product of lipid peroxidation in disruption of ion homeostasis and neuronal death induced by amyloid ß-peptide. J Neurochem 1997;68: 255-264.
9. Lovell MA, Ehmann WD, Mattson MP, Markesbery WR. Elevated 4-hydroxynonenal in ventricular fluid in Alzheimer's disease. Neurobiol Aging 1997;18:457-461.
10. Markesbery WR, Lovell MA. Four-hydroxynonenal, a product of lipid peroxidation, is increased in the brain in Alzheimer's disease. Neurobiol Aging 1998;19:33-36.
11. Chasseaud LF. The role of glutathione and glutathione S-transferases in the metabolism of chemical carcinogens and other electrophilic agents. Adv Cancer Res 1979;29:175-274.
12. Mannervik B, Alin P, Guthenberg G, et al. Identification of three classes of cytosolic glutathione transferase common to several mammalian species: correlation between structural data and enzymatic properties. Proc Natl Acad Sci USA 1985; 82:7202-7206.
13. Meyer DJ, Coles B, Pemble SE, Gilmore KS, Fraser GM, Ketterer B. Theta, a new class of glutathione transferases purified from rat and man. Biochem J 1991;274:409-414.
14. DeJong JL, Morgenstern R, Jomvall H, DePierre JW, Tu C-P. Gene expression of rat and human microsomal glutathione S-transferases. Biol Chem 1988;263:8430-8436.
15. Alin P, Mannervik B, Jornvall H. Structural evidence for three different types of glutathione transferase in human tissues. FEES Lett 1985;182:319-322.
16. Warholm M, Guthenberg C, Mannervik B. Molecular and catalytic properties of glutathione transferase mu from human liver: an enzyme efficiently conjugating epoxides. Biochemistry 1983;22:3610-3617.
17. Tipping E, Ketterer B. The role of intracellular proteins in the transport and metabolism of lipophilic compounds. In: Blauer G, Sund H, eds. Transport by protein. Berlin: Walter de Gruyter, 1978:369.
18. Christ-Hazelhof E, Nugteren DH, Van Dorp DA. Conversions of prostaglandin endoperoxides by glutathione S-transferases and serum albumins. Biochem Biophys Res Commun 1976; 450:450-461.
19. 2α catalyzed by glutathione S-transferases. Biochem Biophys Res Commun 1985; 142:441-447.
20. Warholm M, Guthenberg C, Mannervik B, VonBahr C. Purification of a new glutathione S-transferase (transferase mu) from human liver having high activity with benzo (alpha) pyrene-4,5-oxide. Biochem Biophys Res Commun 1981;98: 512-519.
21. Michael A. Uber die addition von Natriummacetessig-und Natriummalunsaureathern zu den Athern ungesattigter sauren. J Prakt Chem 1887;35:349-359.
22. Mannervik B, Danielson UH. Glutathione transferasesstructure and catalytic activity. Grit Rev Biochem 1988;23: 283-337.
23. Ketterer B, Tan KH, Meyer DJ, Coles B. Glutathione transferases: a possible role in the detoxification of DNA and lipid hydroperoxides. In: Mantle RJ, Pickett CB, Hayes JD, eds. Glutathione S-transferases and carcinogenesis. London: Taylor & Francis, 1987:149.
24. Spearman ME, Prough RA, Estabrook RW, et al. Novel glutathione conjugates formed from epoxyeicosatrienoic acids (EETs). Arch Biochem Biophys 1985;242:225-230.
25. Meyer DJ, Ketterer B. 5 Alpha, 6 alpha-epoxy-cholestan-3 beta-ol (cholesterol alpha-oxide): a specific substrate for rat liver glutathione transferase B. FEES Lett 1982;150:499-502.
26. Danielson UH, Esterbauer H, Mannervik B. Structureactivity relationships of 4-hydroxyalkenals in the conjugation catalyzed by mammalian glutathione transferases. Biochem J 1987;247:707-713.
27. Xie CS, Lovell MA, Markesbery WR. Glutathione transferase protects neuronal cultures against 4-hydroxynonenal toxicity. Free Radie Biol Med 1998; in press.
28. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of the Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 1984;34:939-944.
29. National Institute on Aging, and Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer's Disease. Consensus recommendations for the postmortem diagnosis of Alzheimer's disease. Neurobiol Aging 1997;18:S1-S2.
30. Braak H, Braak E. Pathology of Alzheimer's disease. In: Calne DB, ed. Neurodegenerative diseases. Philadelphia: W.B. Saunders, 1994:585-613.
31. Wenstrup D, Ehmann WD, Markesbery WR. Trace element imbalances in isolated subcellular fractions of Alzheimer's disease brain. Brain Res 1990;533:125-131.
32. Ricci G, Caccuri AM, Lo Bello M, Pastore A, Piemonte F, Federici G. Colorimetric and fluorometric assays of glutathione transferase based on 7-chloro-4-nitrobenzo-2-oxa-l,3diazole. Anal Biochem 1994;218:463-465.
33. Lowry O, Rosebrough N, Farr A, Randall R. Protein measurement with the Folin phenol reagent. J Biol Chem 1951;193: 263-275.
34. Scidegard J, Pero RW. The hereditary transmission of high glutathione transferase activity towards trans-stilbene oxide in human mononuclear leukocytes. Hum Genet 1985;69: 66-68.
35. Montine KS, Kim PJ, Olson SJ, Markesbery WR, Montine TJ. 4-Hydroxy-2-nonenal pyrrole adducts in human neurodegenerative disease. J Neuropathol Exp Neurol 1997;56:866-871.
36. Sayre LM, Zelasko DA, Harris PL, Perry G, Salomon RG, Smith MA. 4-Hydroxynonenal-derived advanced lipid peroxidation end products are increased in Alzheimer's disease. J Neurochem 1997;68:2092-2097.
37. Perry TL, Yong VW, Bergeron C, Hansen S, Jones K Amino acids, glutathione, and glutathione transferase activity in the brains of patients with Alzheimer's disease. Ann Neurol 1987; 21:331-336.
38. Sian J, Dexter DT, Lees AJ, Daniel S, Jenner P, Marsden CD. Glutathione related enzymes in brain in Parkinson's disease. Ann Neurol 1994;36:356-361.